Clinical Trials Logo

No Evidence of Disease clinical trials

View clinical trials related to No Evidence of Disease.

Filter by:

NCT ID: NCT03725449 Completed - Melanoma Clinical Trials

Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma

Start date: November 3, 2018
Phase: N/A
Study type: Interventional

This trial studies an internet-based intervention for skin self-examination (SSE) in participants at increased risk for melanoma. Early detection of suspicious growths on the skin can be done by performing regular SSE checks. Using an internet-based intervention, such as mySmartCheck, may help to promote regular, thorough checks on the skin in individuals at increased risk for melanoma.

NCT ID: NCT03284346 Terminated - Obesity Clinical Trials

Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors

Start date: August 17, 2017
Phase: N/A
Study type: Interventional

This randomized pilot clinical trial studies how well circuit, interval-based aerobic and resistance exercise works in targeting metabolic dysregulation in stage I-III breast or prostate cancer survivors. Circuit, interval-based aerobic and resistance exercise may help to improve cardiovascular fitness, weight loss, healthy lifestyle behaviors, and muscle strength in breast or prostate cancer survivors.

NCT ID: NCT03156309 Recruiting - Clinical trials for Stage IIIA Breast Cancer

Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission

WOKVAC
Start date: September 2016
Phase: Phase 1
Study type: Interventional

This phase I trial studies the side effects and best dose of a vaccine therapy in preventing cancer from coming back in patients with non-metastatic, node positive, human epidermal growth factor receptor (HER)2 negative breast cancer in which all signs and symptoms have disappeared. Vaccines made from deoxyribonucleic acid (DNA) may help the body build an effective immune response to kill tumor cells. Giving multiple vaccinations may make a stronger immune response and prevent or delay the return of cancer.

NCT ID: NCT03120390 Withdrawn - Cancer Survivor Clinical Trials

Physical Activity in Reducing Metabolic Dysregulation (MetD) in Obese Latina Breast Cancer Survivors

Start date: March 8, 2019
Phase: N/A
Study type: Interventional

This randomized phase II trial studies how well physical activity works in reducing metabolic dysregulation in obese Latina breast cancer survivors. Physical activity may improve fitness and lessen metabolic disease (such as coronary artery disease, stroke, and type 2 diabetes) risk factors in patients who have breast cancer.

NCT ID: NCT02961790 Completed - Breast Carcinoma Clinical Trials

Oxybutynin Chloride in Managing Hot Flashes

Start date: December 9, 2016
Phase: Phase 3
Study type: Interventional

This randomized phase III trial studies how well oxybutynin chloride works in managing hot flashes in patients who are not candidates for, or not interested in hormone replacement therapy. Previous studies have shown that oxybutynin is effective in managing hot flashes, however doses used in prior studies have resulted in side effects. This trial is evaluating lower doses of oxybutynin with the goal of determining if they are efficacious with less side effects. ADAM-VTE

NCT ID: NCT02780401 Active, not recruiting - Clinical trials for Stage IIIA Breast Cancer

Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission

WOKVAC
Start date: September 2, 2016
Phase: Phase 1
Study type: Interventional

This phase I trial studies the side effects and best dose of a vaccine therapy in preventing cancer from coming back in patients with non-metastatic, node positive, human epidermal growth factor receptor (HER)2 negative breast cancer in which all signs and symptoms have disappeared. Vaccines made from deoxyribonucleic acid (DNA) may help the body build an effective immune response to kill tumor cells. Giving multiple vaccinations may make a stronger immune response and prevent or delay the return of cancer.

NCT ID: NCT02735512 Terminated - Clinical trials for Stage III Bladder Cancer

MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer

Start date: March 1, 2016
Phase:
Study type: Observational

This pilot research trial studies how well myeloid derived suppressor cells (MDSC) clinical assay works in finding and monitoring cancer cells in blood and urine samples from patients with or without localized or metastatic bladder cancer. Studying samples of blood and urine from patients with or without bladder cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer and may help doctors improve ways to diagnose and treat patients.

NCT ID: NCT02288416 Completed - Anxiety Clinical Trials

Video-Based Intervention in Reducing Anxiety in Patients Undergoing Lung Cancer Screening

Start date: December 8, 2014
Phase: N/A
Study type: Interventional

This pilot trial studies a video-based intervention in reducing anxiety in patients undergoing lung cancer screening. Giving a video-based intervention to patients prior to lung cancer screening may reduce anxiety and improve the well-being and quality of life.

NCT ID: NCT02099136 Completed - Clinical trials for No Evidence of Disease

Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy Volunteers

Start date: September 1999
Phase: Phase 2
Study type: Interventional

This randomized clinical trial studies if celecoxib will prevent the damaging effects of sunburn in healthy volunteers. Exposure to ultraviolet light can induce erythema, sunburn or skin redness caused by inflammation. Celecoxib may reduce skin damage by blocking enzymes associated with sunburn in healthy volunteers. Studying samples of skin in the laboratory from patients receiving ultraviolet-radiation before and after celecoxib treatment may help doctors learn more about the effects celecoxib has on cells.

NCT ID: NCT02090933 Completed - Clinical trials for No Evidence of Disease

Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy Volunteers

Start date: March 2004
Phase: Phase 2
Study type: Interventional

This clinical trial studies celecoxib in decreasing the damaging effects of sunburn in healthy volunteers. Celecoxib may reduce skin damage by blocking enzymes associated with sunburn in healthy volunteers.